Non-Resectable Cholangiocarcinoma
3 clinical trials · Condition
◉ Watch Non-Resectable Cholangiocarcinoma
| Record | Firm | Date |
|---|---|---|
| TAS102 in Combination With NAL-IRI in Advanced GI Cancers (NCT03368963) | Emory University | 2018-01-30 |
| Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma (NCT02856568) | Mayo Clinic | 2017-05-01 |
| Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors (NCT02495896) | University of Southern California | 2015-09-03 |
Track Non-Resectable Cholangiocarcinoma automatically
Every clearance here is in the API, with alerts when new ones post.